COVID-19 Update: May 27
Previously reported data from the National Institute of Allergy and Infectious Diseases study of remdesivir was publicly released over the weekend. According to the preliminary report, remdesivir shortened recovery time from 15 days to 11 days in hospitalized patients. On Tuesday, Merck announced it is developing two different vaccines for COVID-19. The drugmaker is also licensing an oral [...]
